As seen on:
X
LOADING

Here is what our readers say:

"You are one of the most interesting, talented writers I know" A.G.
"Thanks for your ideas and advice over the last few years" D.M.
"I look forward to your emails. They are among the very few that pass my screen." J.C.
"The world needs more of voices like yours" B.W.
"I don't know anyone else that writes like you, shares market points of view like you, and makes things seem personal and approachable!" J.C.
"Thanks for your ideas and advice over the last few years." D.M.

Here’s Why Pharmacy Stocks Are a Bargain Right Now

Listen on: iTunes | Google Podcasts | Online My investment management firm’s portfolio has a large position in the health-care sector, and with AbbVie’s $63 billion takeover bid for Allergan earlier this week, it’s timely to review why we bought into this sector. Without commenting on Allergan shares of which we own, or AbbVie which we do not, health care companies […]

Need I say more?

Walgreens (WAG) comments on Wal-Mart (WMT) “will put them out of business strategy” on the company conference call: For the 291 drugs that Wal-Mart will sell for $4, the average co-pay at Walgreens is $5.30 and for Medicare Part D patients it’s only $3.18. Wal-Mart’s program covers less than 300 generic medications while Walgreens pharmacies’ […]